About SiTOOLs Biotech
SiTOOLs Biotech is a company based in Planegg (Germany) founded in 2013 by Gunter Meister. SiTOOLs Biotech offers products and services including riboPOOLs, siPOOLs, siFractor, raPOOLs, and Phenovault. SiTOOLs Biotech operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Latest Funding Round$83.23K (USD), Grant
Jun 2014
- Investors
Products & Services of SiTOOLs Biotech
SiTOOLs Biotech offers a comprehensive portfolio of products and services, including riboPOOLs, siPOOLs, siFractor, raPOOLs, and Phenovault.
Kits for efficient rRNA depletion in RNA sequencing applications.
Complex siRNA pools for targeted gene knockdown in research.
Tool for RNA fractionation and precise molecular analysis.
Products for advanced RNA-related experimental applications.
Service for RNAi data deconvolution and analysis.
Marker for accurate excision of RNA fragments in gels.
Tools supporting enhanced RNA processing and sequencing.
Apps and channels of SiTOOLs Biotech
its YouTube channel siTOOLs Biotech GmbH has 13 subscribers and 8 videos.
Videos from SiTOOLs Biotech
The most watched videos on SiTOOLs Biotech's YouTube channel, siTOOLs Biotech GmbH (13 subscribers). Click a video to play it here.
More on siTOOLs Biotech GmbH.
Funding Insights of SiTOOLs Biotech
- Total Rounds 1
- Last Round Grant — $83,229
- First Round $83,229
(Jun 2014)
- Investors Count 1
All 1 funding rounds of SiTOOLs Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2014 | $83,229 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in SiTOOLs Biotech
SiTOOLs Biotech has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include BayStartUP.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startups, investors, and industry are connected via a dedicated network. | – | baystartup.de | Nuremberg, Germany |
Investor details for SiTOOLs Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SiTOOLs Biotech
2 people are tracked at SiTOOLs Biotech (2 in leadership).
| Name | Role | Group |
|---|---|---|
Gunter Meister | Co-Founder | Leadership |
Michael Hannus | CEO & MD | Leadership |
Complete people profiles for SiTOOLs Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of SiTOOLs Biotech
2 dated milestones of SiTOOLs Biotech across 1 years, from founding to its latest funding, stage changes and deals.
- Founded SiTOOLs Biotech is founded.
- Funding First funding round of $83K.
Competitors of SiTOOLs Biotech
SiTOOLs Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| lifeminetx.com | 2016 | Cambridge, United States | $300.07M | 85 | Developer of novel drugs from fungi via genome mining and recombinant overexpression |
Detailed competitors of SiTOOLs Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SiTOOLs Biotech
The website of SiTOOLs Biotech (sitoolsbiotech.com) receives about 3.5K visits a month.
- Monthly visits3.5K
▼ 12.8% vs previous month
Websites whose visitors overlap most with SiTOOLs Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| scirhom.com | 100% | – | – | View details | |
biolab-muenchen.de | biolab-muenchen.de | 98% | – | – | – |
ibbnetzwerk-gmbh.com | ibbnetzwerk-gmbh.com | 97% | – | #10,824,615 | – |
| amsilk.com | 94% | 2.6K | #6,008,623 | View details | |
amicusrx.de | amicusrx.de | 94% | – | #10,724,948 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for SiTOOLs Biotech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to SiTOOLs Biotech
10 companies that operate in the same segment as SiTOOLs Biotech (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SiTOOLs Biotech
SiTOOLs Biotech was founded in 2013 and raised its 1st funding round 1 year after it was founded.
SiTOOLs Biotech is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.
Michael Hannus is the current CEO of SiTOOLs Biotech.
SiTOOLs Biotech was founded in 2013 and is based in Planegg, Germany. Operations focus on the biotechnology sector, with expertise in RNA interference, bioinformatics, and RNA research tools for RNA-Seq and Ribo-Seq applications. Services include gene function analysis products such as siPOOL for gene silencing, raPOOL for RNA affinity purification, and riboPOOL for ribosomal RNA depletion. These offerings support research in molecular biology.
SiTOOLs Biotech's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
SiTOOLs Biotech offers riboPOOLs, siPOOLs, siFractor, raPOOLs, and 3 more products and services.
SiTOOLs Biotech has 1 investor. Key investors include BayStartUP.
SiTOOLs Biotech operates through Sitools Biotech Gmbh.